Enteropathy
12
1
1
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.3%
1 terminated out of 12 trials
87.5%
+1.0% vs benchmark
8%
1 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty
Effectiveness of Point-of-use Water Treatment Technologies to Prevent Stunting Among Children in South Africa
Environmental Enteropathy Among Infants and Children With Growth Faltering
Budesonide in Patients With Immune Mediated Enteropathies
Identification of Novel Bio-markers for Environmental Enteropathy in Children Using an Evidence Based Approach
Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy
Study of Environmental Enteropathy and Malnutrition in Pakistan
Childhood Acute Illness and Nutrition Network
The Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction in Rural Malawian Children 6-11 Months
Zinc Resistant Starch Project
Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental Enteropathy
Follow-up Study of Small-intestinal Mucosal Injuries in Chronic Non-steroidal Anti-inflammatory Drugs (NSAIDs)-Users